Median IL-21 serum levels were significantly higher in SSc patients compared to HC [130.25 ng/ml (IQR 57.05–259.78) vs 17.52 ng/ml (IQR 14.83–27.13), p < 0.001]. This evidence concerns the gene IL21 and systemic sclerosis.